Trisalus Life Sciences, Inc. (TLSIW) SEC Filings — 2025

Filings

• TriSalus Revenue Jumps 51%, But Net Loss Widens Amid High Costs — 10-Q · Nov 13, 2025
• TriSalus Life Sciences Announces Board and Officer Changes — 8-K · Oct 1, 2025
• TriSalus Life Sciences Announces Board and Officer Changes — 8-K · Aug 29, 2025
• TriSalus Revenue Jumps 52% Amidst Mounting Losses, Cash Infusion — 10-Q · Aug 12, 2025
• TriSalus Life Sciences Files 8-K on Security Holder Rights & Bylaws — 8-K · Jul 24, 2025
• TriSalus Life Sciences Files 8-K — 8-K · Jun 23, 2025
• TriSalus Life Sciences Reports on Shareholder Vote — 8-K · Jun 16, 2025
• TriSalus Amends 10-K, Reveals Capital Raises Amidst Deficit — 10-K/A · May 30, 2025
• TriSalus Life Sciences Files Q1 2025 10-Q — 10-Q · May 15, 2025
• TriSalus Life Sciences Files 8-K with Key Updates — 8-K · Apr 30, 2025
• TriSalus Life Sciences Files 2025 Proxy Statement — DEF 14A · Apr 30, 2025
• TriSalus Life Sciences Announces Board and Executive Changes — 8-K · Apr 23, 2025
• TriSalus Life Sciences Appoints New CMO, Director — 8-K · Apr 17, 2025
• TriSalus Life Sciences Files 2024 10-K — 10-K · Apr 15, 2025
• TriSalus Life Sciences Files 8-K on Financials — 8-K · Mar 27, 2025
• TriSalus Life Sciences Appoints New CMO, Director — 8-K · Feb 25, 2025
• TriSalus Life Sciences Reports Financial Obligation & Equity Sale — 8-K · Feb 19, 2025
• TriSalus Life Sciences Files 8-K on Financials — 8-K · Feb 3, 2025
• TriSalus Life Sciences Announces Executive and Board Changes — 8-K · Jan 31, 2025
• TriSalus Life Sciences Files 8-K on Financials — 8-K · Jan 23, 2025
• TriSalus Life Sciences Files 8-K on Officer/Director Changes — 8-K · Jan 8, 2025